In 2024, Azerbaijan Caspian shipping Company's (ASCO) ship repair plants, "Zıgh" Ship Repair and construction plant (ZGTTZ) ...
Hosted on MSN2d
Exelixis falls after ASCO releases colorectal cancer dataShares of Exelixis (EXEL) are moving lower after the American Society of Clinical Oncology released an abstract on data for ...
Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after ...
ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving ...
Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors ...
Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.
Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 ...
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium Circulating tumor DNA (ctDNA) analysis and ...
Stage-adjusted sensitivity was 91% in screen-detected individuals. “This data at ASCO GI demonstrates the ongoing strength of Signatera complemented by our exciting innovation pipeline,” said ...
Silexion’s abstract will be published on the ASCO Gastrointestinal Cancers Symposium website at 5:00 p.m. ET on January 21, 2025. Following the presentation, the poster will be available on Silexion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback